All Gut Microbiome articles – Page 10
-
NewsCircadian rhythms as a modulator of gut microbiota-tumor microenvironment crosstalk
A new review examines how circadian disruption modifies the diversity and metabolic functions of gut microbiota, resulting in alterations of microbial metabolites, including short-chain fatty acids and secondary bile acids.
-
NewsHospital bug jumps from lungs to gut, raising sepsis risk
A hospital-acquired bacterium that causes serious infections can move from the lungs to the gut inside the same patient, raising the risk of life-threatening sepsis, new research reveals.
-
NewsNew collection of bacteria-eating viruses can tackle hospital superbug
An international team of researchers have comprehensively catalogued a new collection of bacteria-eating viruses called phages sourced, in part, from hospital wastewater. The phages have been shown to be effective against different strains of Klebsiella pneumoniae.
-
NewsToxic gut bacteria may drive ulcerative colitis by killing protective immune cells
A toxin-secreting gut bacterium may fuel ulcerative colitis by killing protective immune cells that maintain intestinal homeostasis, according to a new study. The findings suggest potential for new treatment strategies.
-
NewsWorld’s largest metabolomic study completed, paving way for predictive medicine
UK Biobank has today released the final set of data on nearly 250 metabolites in half a million volunteers. This completes the world’s largest ever metabolomic study, which will help drive treatment strategies for neurological conditions, heart disease and cancer.
-
NewsImpact of pasteurization on dairy calves’ gut microbiota: A study of milk feeding and early microbial colonization
A new study highlights the impact of pasteurization on microbial diversity in dairy calves, underlining the importance of balancing pathogen safety and microbial health. It suggests that while pasteurization prevents pathogen transmission, it also reduces beneficial microbial transfer.
-
NewsBacteria ‘pills’ could detect gut diseases — without the endoscope
Researchers report that they’ve developed a sensor made of tiny microspheres packed with blood-sensing bacteria that detect markers of gastrointestinal disease. Taken orally, the miniature “pills” also contain magnetic particles that make them easy to collect from stool. Excreted from mouse models with colitis, the bacterial sensor detected gastrointestinal bleeding within minutes.
-
NewsProbiotic bifidobacterium may boost cancer treatment and suppress tumors
A new review explores how bifidobacterium, a common probiotic found in the gut, may contribute to cancer prevention and therapy. The authors highlight the growing importance of gut health in cancer treatment and shed light on how bifidobacterium could complement standard cancer therapies.
-
NewsGut bacterium impairs liver cancer treatment, inducing immunotherapy resistance
Researchers discovered that transplanting the gut bacterium Phocaeicola vulgatus into mouse models of liver cancer induced immunotherapy resistance. The finding is consistent with clinical observations in patients, showing that patients with low levels of P. vulgatus responded better to treatment.
-
NewsA microbial blueprint for climate-smart cows
Recent research has shown that feeding cows red seaweed can dramatically cut the amount of methane that is produced and released into the environment. A new study sheds light on that process and reveals which microbes in the cow’s gut might help reduce methane.
-
NewsMedications change our gut microbiome in predictable ways
A study shows that many of the changes to the gut microbiome are driven by competition for nutrients – medications reduce certain bacterial populations and change the availability of nutrients, and the bacteria most able to capitalize on those changes are the ones to survive.
-
NewsNext-generation microbiome medicine may revolutionize the treatment of Parkinson’s and similar disorders
Scientists have engineered the probiotic bacterium Escherichia coli Nissle 1917 as a drug-delivery system that continuously produces and delivers the gold-standard Parkinson’s drug Levodopa, which is converted to dopamine in the brain. E. coli Nissle strain was chosen for its century-long record of safely treating gastrointestinal disorders in humans.
-
NewsNew DNA analysis approach could transform understanding of disease evolution
By adapting techniques originally used to study ancient DNA from archaeological specimens, researchers were able to recover genetic information from nearly century-old medical samples.
-
NewsThe link between the gut microbiome and autism is not backed by science, researchers say
There’s no scientific evidence that the gut microbiome causes autism, a group of scientists argue in an opinion paper. They warn that conclusions that supported this hypothesis are undermined by flawed assumptions, small sample sizes, and inappropriate statistical methods.
-
NewsScientists find way to find the gut microbiome into a longevity factory
A team of researchers has found a way to turn the bacteria living in the digestive tracts of animals into factories that can produce compounds that promote longevity in their hosts—showing a potential new drug development strategy.
-
NewsFirst-in-North-America resource touts research into health benefits of fermented foods
A one-stop network, the first of its kind in North America, has begun sharing easily digested research, recipes and other resources about the health benefits of fermented foods. The new Canadian Fermented Foods Initiative (CFFI) launches officially on Nov. 17.
-
NewsGut microbiota: implications in pathogenesis and potential therapeutic target in primary biliary cholangitis
A new review synthesizes current evidence on gut microbiota dysbiosis in PBC, elucidates its pathogenic mechanisms, and explores its potential as both a diagnostic biomarker and a novel therapeutic target.
-
NewsSecrets of microbial motion: How bacteria swash, glide and shift gears to survive
Two new studies reveal surprising ways microbes move, with implications for human health and disease. The first shows that salmonella and E. coli can ’swash’ across moist surfaces even when their flagella are disabled, while the second probes the T9SS gearbox in flavobacteria.
-
NewsLow-dose cannabis compound reduces side effects of HIV treatment
Long-term, low doses of THC mitigate many harmful side effects and inflammation caused by HIV and antiretroviral therapy (ART). Benefits included increased production of serotonin, while inflammation, cholesterol and harmful secondary bile acids were all reduced.
-
NewsThe ‘MDME Axis’: A new view on how microbial metabolites epigenetically shape host health
A review introduces the ’MDME Axis’, a new framework explaining how metabolites from the gut microbiome epigenetically reprogram our genes, influencing host health and disease.